tiprankstipranks
Trending News
More News >
Citius Oncology (CTOR)
NASDAQ:CTOR
US Market

Citius Oncology (CTOR) Income Statement

Compare
129 Followers

Citius Oncology Income Statement

Last quarter (Q3 2025), Citius Oncology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Citius Oncology's net income was $-5.37M. See Citius Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 20.57M$ 12.12M$ 4.86M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00
EBITDA
$ -20.57M$ -12.12M$ -4.86M
Operating Income
$ -20.57M$ -12.12M$ -4.86M
Other Income/Expenses
$ 0.00$ 0.00$ 0.00
Pretax Income
$ -20.57M$ -12.12M$ -4.86M
Net Income
$ -21.15M$ -12.70M$ -5.43M
Per Share Metrics
Basic EPS
$ -0.30$ -0.19$ -0.08
Diluted EPS
$ -0.30$ -0.19$ -0.08
Weighted Average Shares Outstanding
71.55M 89.48M 90.16M
Weighted Average Shares Outstanding (Diluted)
71.55M 89.48M 90.16M
Currency in USD

Citius Oncology Earnings and Revenue History